Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS

Journal of NeuroVirology

Volumn 11, Issue 4, 2005, Pages 346-355

  Hammoud, Dima A ^a   Endres, Christopher J ^a   Chander, Ankit R ^a   Guilarte, Tomas R ^b   Wong, Dean F ^a   Sacktor, Ned C ^a   McArthur, Justin C ^a   Pomper, Martin G ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; HIV dementia; Peripheral benzodiazepine receptor; PET; PK11195

Indexed keywords

N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CARBON; DIAGNOSTIC AGENT; ISOQUINOLINE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC VALUE; FEMALE; GLIA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; LIGAND BINDING; MALE; MOLECULAR IMAGING; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANK SUM TEST; VOLUNTEER; BRAIN; GLIA; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; AIDS DEMENTIA COMPLEX; ANTINEOPLASTIC AGENTS; BRAIN; CARBON RADIOISOTOPES; FEMALE; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; NEUROGLIA; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 27144462689     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280500187351     Document Type: Article

References (58)

1. Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, Tardieu. M, Gray F (1999). Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 25:123-133.
2. American Academy of Neurology AIDS Task Force A (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41: 778-785.
3. Banati RB (2002). Visualising microglial activation in vivo. Glia 40: 206-217.
4. 11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 53: 2199-2203.
5. 3H]PK11195 binding to activated microglia. J Neurocytol 26: 77-82.
6. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R (2000). The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123(Pt 11): 2321-2337.
7. Bell JE, Busuttil A, Ironside JW, Rebus S, Donaldson YK, Simmonds P, Peutherer JF (1993). Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 168: 818-824.
8. Benavides J, Bourdiol F, Dubois A, Scatton B (1991). Regional pattern of increased omega 3 (peripheral type benzodiazepine) binding site densities in the rat brain induced by systemic injection of kainic acid. Neurosci Lett 125: 219-222.
9. Brew BJ, Corbeil J, Pemberton L, Evans L, Saito K, Penny R, Cooper DA, Heyes MP (1995). Quinolinic acid production is related to macrophage tropic isolates of HIV-1. J NeuroVirol 1: 369-374.
10. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB (2001a). In-vivo measurement of activated microglia in dementia. Lancet 358: 461-467.
11. 11C] (R)-PK1195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 124: 2014-2027.
12. Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA (2004). A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage 23: 1336-1347.
13. Chen MK, Baidoo K, Verina T, Guilarte TR (2004). Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain 127: 1379-1392.
14. Chen P, Mayne M, Power C, Nath A (1997). The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J Biol Chem 272: 22385-22388.
15. Conant K, Ma M, Nath A, Major EO (1996). Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol 70: 1384-1389.
16. 11C]PK11195 in normal human brain and application in multiple sclerosis patients. Acta Neurol Belg 102: 127-135.
17. 11C]PK11195. Eur J Neurol 10: 257-264.
18. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE (1994). Performance characteristics of a whole-body PET scanner. J Nucl Med 35: 1398-1406.
19. Donaldson YK, Bell JE, Ironside JW, Brettle RP, Robertson JR, Busuttil A, Simmonds P (1994). Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 343: 383-385.
20. Ernst T, Chang L, Arnold S (2003). Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage 19: 1686-1693.
21. Garden GA (2002). Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40: 240-251.
22. Gartner S (2000). HIV infection and dementia. Science 287: 602-604.
23. Gartner S, Liu Y (2002). Insights into the role of immune activation in HIV neuropathogenesis. J NeuroVirol 8: 69-75.
24. Gelbard HA, Nottet HS, Swindells S, Jett M, Dzenko KA, Genis P, White R, Wang L, Choi YB, Zhang D, et al. (1994). Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 68: 4628-4635.
25. Groom GN, Junck L, Foster NL, Frey KA, Kuhl DE (1995). PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. J Nucl Med 36: 2207-2210.
26. Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF (2000). Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol 27: 627-630.
27. Ilyin SE, Plata-Salaman CR (1997). HIV-1 envelope glycoprotein 120 regulates brain IL-1beta system and TNF-alpha mRNAs in vivo. Brain Res Bull 44: 67-73.
28. Jaranowska A, Bussolino F, Sogos V, Arese M, Lauro GM, Gremo F (1995). Platelet-activating factor production by human fet al microglia. Effect of lipopolysaccharides and tumor necrosis factor-alpha. Mol Chem Neuropathol 24: 95-106.
29. Kaul M, Garden GA, Lipton SA (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994.
30. Kaul M, Lipton SA (2004). Signaling pathways to neuronal damage and apoptosis in human immunodeficiency virus type 1-associated dementia: chemokine receptors, excitotoxicity, and beyond. J NeuroVirol 10(Suppl 1): 97-101.
31. Kort JJ (1998). Impairment of excitatory amino acid transport in astroglial cells infected with the human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 14: 1329-1339.
32. 11C](R)-PK11195 studies. NeuroImage 22: T184-T185.
33. Kuhlmann AC, Guilarte TR (1999). Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity. Toxicol Sci 48: 107-116.
34. Kuhlmann AC, Guilarte TR (2000). Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem 74: 1694-1704.
35. Kure K, Lyman WD, Weidenheim KM, Dickson DW (1990). Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol 136: 1085-1092.
36. Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, Jarvik JG, Richards TL, Kwok EW, Kolson DL, Simpson D, Tang CY, Schifitto G, Ketonen LM, Meyerhoff DJ, Lenkinski RE, Gonzalez RG, Navia BA (2003). A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging 17: 625-633.
37. Lipton SA (1993). Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor mediated neurotoxicity. Ann Neurol 33: 227-228.
38. Mankowski JL, Queen SE, Tarwater PJ, Adams RJ, Guilarte TR (2003). Elevated peripheral benzodiazepine receptor expression in simian immunodeficiency virus encephalitis. J Neuro Virol 9: 94-100.
39. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N (2003). Human immunodeficiency virus-associated dementia: an evolving disease. J NeuroVirol 9: 205-221.
40. 3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion. J Cereb Blood Flow Metab 11: 314-322.
41. Neuen-Jacob E, Arendt G, Wendtland B, Jacob B, Schneeweis M, Wechsler W (1993). Frequency and topographical distribution of CD68-positive macrophages and HIV-1 core proteins in HIV-associated brain lesions. Clin Neuropathol 12: 315-324.
42. Nicolini A, Ajmone-Cat MA, Bernardo A, Levi G, Minghetti L (2001). Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-kappaB activation and oxidative stress in microglial cultures by independent mechanisms. J Neurochem 79: 713-716.
43. 11C]PK1195. Neurology 55: 1052-1054.
44. 3H]PK11195 and [18F]PK14105 as markers for neuronal damage. J Neurochem 55: 175-185.
45. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS (1997). Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692-695.
46. Robb RA (2001). The biomedical imaging resource at Mayo Clinic. IEEE Trans Med Imaging 20: 854-867.
47. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ (1997). Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol 151: 1341-1351.
48. Sauvageau A, Desjardins P, Lozeva V, Rose C, Hazell AS, Bouthillier A, Butterwort RF (2002). Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis. Metab Brain Dis 17: 3-11.
49. Stephenson DT, Schober DA, Smalstig EB, Mincy RE, Gehlert DR, Clemens JA (1995). Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci 15: 5263-5274.
50. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD (1996). Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 39: 705-711.
51. 11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15: 601-609.
52. Vallat AV, De Girolami U, He J, Mhashilkar A, Marasco W, Shi B, Gray F, Bell J, Keohane C, Smith TW, Gabuzda D (1998). Localization of HIV-1 co-receptors CG-R5 and CXCR4 in the brain of children with AIDS. Am J Pathol 152: 167-178.
53. Venneti S, Lopresti BJ, Wang G, Bissel SJ, Mathis CA, Meltzer CC, Boada F, Capuano S, 3rd, Kress GJ, Davis DK, Ruszkiewicz J, Reynolds IJ, Murphey-Corb M, Trichel AM, Wisniewski SR, Wiley CA (2004). PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS. J Clin Invest 113: 981-989.
54. von Giesen HJ, Wittsack HJ, Wenserski F, Koller H, Hefter H, Arendt G (2001). Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1. Arch Neurol 58: 1281-1286.
55. Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, Antel JP (1997). PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 50: 345-353.
56. Ward JM, O'Leary TJ, Baskin GB, Benveniste R, Harris CA, Nara PL, Rhodes RH (1987). Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections. Am J Pathol 127: 199-205.
57. Wesselingh SL, Takahashi K, Glass JD, McArthur JC, Griffin JW, Griffin DE (1997). Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J Neuroimmunol 74: 1-8.
58. Yeh MW, Kaul M, Zheng J, Nottet HS, Thylin M, Gendelman HE, Lipton SA (2000). Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l-cysteine. J Immunol 164: 4265-4270.